share_log

Concerns Surrounding Qingdao Kingking Applied Chemistry's (SZSE:002094) Performance

Concerns Surrounding Qingdao Kingking Applied Chemistry's (SZSE:002094) Performance

圍繞青島金王應用化學 (SZSE: 002094) 業績的擔憂
Simply Wall St ·  04/26 18:52

Qingdao Kingking Applied Chemistry Co., Ltd.'s (SZSE:002094) robust recent earnings didn't do much to move the stock. We think this is due to investors looking beyond the statutory profits and being concerned with what they see.

青島金王應用化學有限公司's(SZSE:002094)近期強勁的收益並沒有對該股產生太大影響。我們認爲這是由於投資者將目光投向了法定利潤之外並關注他們所看到的情況。

earnings-and-revenue-history
SZSE:002094 Earnings and Revenue History April 26th 2024
SZSE: 002094 2024 年 4 月 26 日的收益和收入歷史記錄

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

For anyone who wants to understand Qingdao Kingking Applied Chemistry's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥16m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. Qingdao Kingking Applied Chemistry had a rather significant contribution from unusual items relative to its profit to December 2023. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.

對於任何想了解青島金王應用化學在法定數字之外的利潤的人來說,值得注意的是,在過去的十二個月中,從價值1600萬元人民幣的不尋常物品中獲得了法定利潤。雖然我們希望看到利潤增加,但當不尋常的物品做出重大貢獻時,我們往往會更加謹慎一些。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。這正如你所預料的那樣,因爲這些增強被描述爲 “不尋常”。截至2023年12月,青島金王應用化學在不尋常的項目中爲其利潤做出了相當大的貢獻。因此,我們可以推測,這些不尋常的物品使其法定利潤明顯高於原來的水平。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Qingdao Kingking Applied Chemistry.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對青島金王應用化學的資產負債表分析。

Our Take On Qingdao Kingking Applied Chemistry's Profit Performance

我們對青島金王應用化學盈利表現的看法

As previously mentioned, Qingdao Kingking Applied Chemistry's large boost from unusual items won't be there indefinitely, so its statutory earnings are probably a poor guide to its underlying profitability. For this reason, we think that Qingdao Kingking Applied Chemistry's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. On the bright side, the company showed enough improvement to book a profit this year, after losing money last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Qingdao Kingking Applied Chemistry, you'd also look into what risks it is currently facing. At Simply Wall St, we found 1 warning sign for Qingdao Kingking Applied Chemistry and we think they deserve your attention.

如前所述,青島金王應用化學從不尋常項目中獲得的巨大提振不會無限期地存在,因此其法定收益可能無法很好地指導其潛在盈利能力。出於這個原因,我們認爲青島金王應用化學的法定利潤可能不利於其潛在盈利能力,並可能給投資者留下過於積極的印象。好的一面是,該公司在去年虧損之後,表現出了足夠的改善,今年實現了盈利。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。如果你想更深入地了解青島金王應用化學,你還需要研究它目前面臨的風險。在Simply Wall St,我們發現了青島金金金應用化學的1個警告標誌,我們認爲它們值得你關注。

This note has only looked at a single factor that sheds light on the nature of Qingdao Kingking Applied Chemistry's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

這份報告只研究了揭示青島金金金應用化學利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。有些人認爲高股本回報率是優質業務的好兆頭。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論